rs12453407
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_198834.3(ACACA):c.3246+2454T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.646 in 152,056 control chromosomes in the GnomAD database, including 34,706 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.65 ( 34706 hom., cov: 31)
Consequence
ACACA
NM_198834.3 intron
NM_198834.3 intron
Scores
1
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.143
Publications
6 publications found
Genes affected
ACACA (HGNC:84): (acetyl-CoA carboxylase alpha) Acetyl-CoA carboxylase (ACC) is a complex multifunctional enzyme system. ACC is a biotin-containing enzyme which catalyzes the carboxylation of acetyl-CoA to malonyl-CoA, the rate-limiting step in fatty acid synthesis. There are two ACC forms, alpha and beta, encoded by two different genes. ACC-alpha is highly enriched in lipogenic tissues. The enzyme is under long term control at the transcriptional and translational levels and under short term regulation by the phosphorylation/dephosphorylation of targeted serine residues and by allosteric transformation by citrate or palmitoyl-CoA. Multiple alternatively spliced transcript variants divergent in the 5' sequence and encoding distinct isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ACACA Gene-Disease associations (from GenCC):
- acetyl-coa carboxylase deficiencyInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.964 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.646 AC: 98093AN: 151938Hom.: 34633 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
98093
AN:
151938
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.646 AC: 98228AN: 152056Hom.: 34706 Cov.: 31 AF XY: 0.653 AC XY: 48548AN XY: 74330 show subpopulations
GnomAD4 genome
AF:
AC:
98228
AN:
152056
Hom.:
Cov.:
31
AF XY:
AC XY:
48548
AN XY:
74330
show subpopulations
African (AFR)
AF:
AC:
37491
AN:
41492
American (AMR)
AF:
AC:
10524
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
AC:
1422
AN:
3468
East Asian (EAS)
AF:
AC:
5104
AN:
5172
South Asian (SAS)
AF:
AC:
3367
AN:
4818
European-Finnish (FIN)
AF:
AC:
6346
AN:
10572
Middle Eastern (MID)
AF:
AC:
165
AN:
292
European-Non Finnish (NFE)
AF:
AC:
32199
AN:
67948
Other (OTH)
AF:
AC:
1287
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1478
2956
4434
5912
7390
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.